Pharmacy Financing Company | National Business Capital
Skip to Content

Pharmacy Financing Company

Financing built around pharmacy cash flow. National Business Capital funds pharmacies as a direct lender, with financing up to $15M and no minimum FICO required for most products. An advisor reviews how your pharmacy earns before recommending a structure. That means a pharmacy covering a reimbursement gap gets a different solution than a pharmacy acquiring a new store.

Apply For Pharmacy Financing Now
Funded to Businesses$3B+
Years in Business18
Five-Star Reviews3,000+
Funding AvailableUp to $15M

Why choose National for pharmacy financing

Here’s how National compares with other pharmacy financing companies:

Business advisor helping a client review financing options
$15MAvailable

How it works

How National funds a pharmacy

Pharmacy financing company National starts with your immediate need for capital, then determines the financing structure that best fits it:

  1. 1

    Tell an advisor what you need capital to accomplish:

    Covering wholesaler invoices during a slow reimbursement quarter calls for a different structure than buying a second location or remodeling for clinical services.

  2. 2

    Share your pharmacy’s financial picture:

    Your advisor reviews how reimbursement flows through your pharmacy, weighing the full picture well beyond a credit score.

  3. 3

    Compare structures side by side:

    Your advisor models repayment against your reimbursement cycle so payments don’t come due before the money does.

  4. 4

    Get funded:

    Eligible accounts receive funding in hours, and most applications resolve within three business days.

Contact an Advisor Today
Funding problems pharmacies bring to National

Every pharmacy funding request ultimately comes down to timing. Cash leaves for inventory long before reimbursement arrives, creating pressure points that most often appear in these areas:

Get Funded Now
Brand reimbursement below acquisition cost

The greatest challenge independent pharmacies face? It’s PBMs reimbursing pharmacies for brand-name drugs at less than acquisition cost, according to Avalere Health. A Line of Credit lets you keep filling high-cost scripts without draining the operating account every cycle.

The post-DIR reimbursement squeeze

Since January 1, 2024, CMS has required Part D plans to reflect pharmacy DIR fees in the negotiated price at the point of sale, which lowered the check on every Part D claim. Cash Flow Financing replaces the working capital those smaller checks removed while you adjust your payer strategy.

GLP-1 inventory that ties up thousands per shelf

Drug Channels reports that many pharmacies receive reimbursements below their cost of goods on GLP-1 prescriptions purchased through a wholesaler. Financing carries that inventory burden so one drug class cannot dictate your entire cash position.

Acquisition opportunities created by closures

Independent pharmacies closed at a rate of more than one per day, according to NCPA’s 2024 Digest. Owners with ready capital can purchase script files or entire stores at favorable prices, and a Term Loan or Private Credit funds the purchase before another buyer steps in.

Bank declines

Banks often see compressed prescription margins as a risk. National evaluates revenue and cash flow performance, keeping funding available to pharmacies that traditional underwriting screens out.

Choosing the right funding structure for your pharmacy

Each funding structure solves a different timing problem, and the right choice depends on, as our analysis in the table below shows:

Funding StructurePharmacy UseWhy It Fits
Line of CreditWeekly wholesaler payments during reimbursement lagYou draw only what the gap requires and repay as claims settle
Cash Flow FinancingWorking capital after the 2024 DIR changeNational secures it against cash flow performance
Term LoanStore acquisitionFixed structure for a one-time investment with a long payoff
Term LoanRenovation or clinical services buildoutSpreads a large project cost across the years it generates revenue
Private CreditMulti-location expansion above bank capsFunding reaches up to $15M through National’s direct lending

Pharmacy financing best practices

These best practices can help you choose the right financing and avoid costly cash-flow gaps:

Arrange flexible capital before the crunch arrives

The 2024 DIR transition hit hardest in the first months of the year, when pharmacies paid trailing fees on 2023 claims while new claims settled at lower point-of-sale prices. Owners who secure a Line of Credit while financials look strong typically borrow on better terms than owners who apply mid-squeeze.

Match the repayment length to what the capital buys

Inventory that turns in 30 days should never carry a 5-year loan, and a store acquisition should never lean on short-term credit. Your advisor aligns the financing term with the life of the investment.

Structure today’s funding so it can improve later

National has helped businesses that couldn’t secure government loans access capital they can refinance once their financials strengthen. A pharmacy can fund growth now and move into a lower-cost structure as performance improves.

As a direct lender, National offers the speed and control of balance-sheet lending while also working closely with capital providers when a situation calls for a more tailored solution. Most products require no collateral, so you don’t have to pledge your script files or building to qualify. With $3B+ funded to date, National’s advisors have structured capital for healthcare businesses facing the same reimbursement pressures your pharmacy deals with every week.

Contact an Advisor Today

Frequently asked questions

Eligible accounts receive funding in hours, and most applications resolve within three business days.

Most products require no collateral. National secures funding against cash flow performance, which reflects how a pharmacy earns.

Yes. Financing reaches up to $15M through National’s Direct Lending, which covers single-store purchases that exceed SBA caps.

National evaluates the full business picture. A bank decline does not end the process; an advisor looks at and whether a structure fits your cash flow.

Why choose National Business Capital for pharmacy financing

Most lenders see a pharmacy’s shrinking gross margin and stop there. National’s advisors see a $103 billion industry, according to the 2025 NCPA Digest, where pharmacy owners with the right capital can acquire stores that close around them. Your advisor looks at the pharmacy over the next six months to five years, then recommends the financing structure that supports it, even if a smaller or simpler transaction makes more sense. Because National builds long-term capital relationships with the companies it supports, that advisor stays with you for the next round of funding.

Ready to finance your pharmacy?

Get Funded
Back to top
Smart capital. Smarter decisions.

Be first to know when new offers, rate changes, or seasonal funding trends hit.

This field is for validation purposes and should be left unchanged.
By submitting my email here, I agree to the Terms and Conditions and Privacy Policy, which include our ability to contact you and send you promotional, educational and marketing materials.